Chantal Mengus

928 total citations
22 papers, 648 citations indexed

About

Chantal Mengus is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Chantal Mengus has authored 22 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Chantal Mengus's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chantal Mengus is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chantal Mengus collaborates with scholars based in Switzerland, United States and Italy. Chantal Mengus's co-authors include Giulio C. Spagnoli, Giandomenica Iezzi, Michael Heberer, Stephen Wyler, Alexander Bachmann, Lukas Bubendorf, Manuele Giuseppe Muraro, Clémentine Le Magnen, Paul Zajac and Luigi Terracciano and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Virology.

In The Last Decade

Chantal Mengus

22 papers receiving 642 citations

Peers

Chantal Mengus
Gang Xue China
Heather L. Machado United States
Sugandha Saxena United States
Junna Oba Japan
Kari J. Dugger United States
Chantal Mengus
Citations per year, relative to Chantal Mengus Chantal Mengus (= 1×) peers Marco Gerling

Countries citing papers authored by Chantal Mengus

Since Specialization
Citations

This map shows the geographic impact of Chantal Mengus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Mengus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Mengus more than expected).

Fields of papers citing papers by Chantal Mengus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Mengus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Mengus. The network helps show where Chantal Mengus may publish in the future.

Co-authorship network of co-authors of Chantal Mengus

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Mengus. A scholar is included among the top collaborators of Chantal Mengus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Mengus. Chantal Mengus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mengus, Chantal, Claudia C. Bippes, Corina Kohler, et al.. (2021). VCP/p97 cofactor UBXN1/SAKS1 regulates mitophagy by modulating MFN2 removal from mitochondria. Autophagy. 18(1). 171–190. 27 indexed citations
2.
Banzola, Irina, Chantal Mengus, Stephen Wyler, et al.. (2018). Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression. Frontiers in Immunology. 9. 1051–1051. 58 indexed citations
3.
Hudolin, Tvrtko, et al.. (2017). Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas. Anticancer Research. 37(3). 1375–1380. 13 indexed citations
4.
Zajac, Paul, Elke Schultz‐Thater, Luigi Tornillo, et al.. (2017). MAGE-A Antigens and Cancer Immunotherapy. Frontiers in Medicine. 4. 18–18. 61 indexed citations
5.
Mengus, Chantal, Manuele Giuseppe Muraro, Valentina Mele, et al.. (2017). In Vitro Modeling of Tumor–Immune System Interaction. ACS Biomaterials Science & Engineering. 4(2). 314–323. 18 indexed citations
6.
Dasen, Boris, Tatjana Vlajnic, Chantal Mengus, et al.. (2016). T‐cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance. The Journal of Pathology Clinical Research. 3(1). 44–57. 8 indexed citations
7.
Hirt, Christian, Adam Papadimitropoulos, Manuele Giuseppe Muraro, et al.. (2015). Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed “in vivo”. Biomaterials. 62. 138–146. 52 indexed citations
8.
Trella, Emanuele, Nermin Raafat, Chantal Mengus, et al.. (2015). CD40 ligand‐expressing recombinant vaccinia virus promotes the generation of CD8+ central memory T cells. European Journal of Immunology. 46(2). 420–431. 9 indexed citations
9.
Hirt, Christian, Adam Papadimitropoulos, Valentina Mele, et al.. (2014). “In vitro” 3D models of tumor-immune system interaction. Advanced Drug Delivery Reviews. 79-80. 145–154. 69 indexed citations
10.
Pamuk, Ömer Nurı, et al.. (2014). Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients. Lupus. 24(8). 816–821. 16 indexed citations
11.
Magnen, Clémentine Le, Lukas Bubendorf, Cyrill A. Rentsch, et al.. (2013). Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer. Clinical Cancer Research. 19(19). 5361–5371. 67 indexed citations
12.
Hudolin, Tvrtko, Željko Kaštelan, Ivana Ilić, et al.. (2013). Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma. Journal of Translational Medicine. 11(1). 123–123. 12 indexed citations
13.
Bubendorf, Lukas, Cyrill A. Rentsch, Chantal Mengus, et al.. (2013). Characterization and Clinical Relevance of ALDH bright Populations in Prostate Cancer. 6 indexed citations
14.
Mengus, Chantal, Elke Schultz‐Thater, Željko Kaštelan, et al.. (2012). MAGE‐A10 cancer/testis antigen is highly expressed in high‐grade non‐muscle‐invasive bladder carcinomas. International Journal of Cancer. 132(10). 2459–2463. 24 indexed citations
15.
Magnen, Clémentine Le, Lukas Bubendorf, Christian Ruiz, et al.. (2012). Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. European Journal of Cancer. 49(4). 955–963. 44 indexed citations
16.
Raafat, Nermin, et al.. (2011). Preventing vaccinia virus class‐I epitopes presentation by HSV‐ICP47 enhances the immunogenicity of a TAP‐independent cancer vaccine epitope. International Journal of Cancer. 131(5). E659–69. 15 indexed citations
17.
Mengus, Chantal, Clémentine Le Magnen, Emanuele Trella, et al.. (2011). Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. Journal of Translational Medicine. 9(1). 162–162. 54 indexed citations
18.
Sconocchia, Giuseppe, Inti Zlobec, Alessandro Lugli, et al.. (2010). Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. International Journal of Cancer. 128(11). 2663–2672. 74 indexed citations
19.
Spagnoli, Giulio C., Marzieh Ebrahimi, Giandomenica Iezzi, Chantal Mengus, & Paul Zajac. (2010). Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.. PubMed. 13(2). 184–92. 4 indexed citations
20.
Page, Guylène, et al.. (1964). [HIGH PLATELET LEVEL DISCOVERED AFTER SPLENECTOMY AND TREATED WITH MYLERAN].. PubMed. 72. 1959–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026